Enhancing Attention and Wellbeing Using Digital Therapeutics
Key claim: A proposed study aims to find the minimal/optimal dose of a digital therapeutic for cognitive enhancement in older adults and test whether cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity moderate treatment effects toward a precision model for dementia-risk populations.
Abstract
The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.
Why this matters
A proposed study aims to find the minimal/optimal dose of a digital therapeutic for cognitive enhancement in older adults and test whether cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity moderate treatment effects toward a precision model for dementia-risk populations.